P.G. Arndt et al., “Expression of Interleukin-1β in the Lung after Endotoxemia of Hemorrhage-Induced Acute Lung Injury,” Am. J. Respir. Cell Mol. Biol., 22, pp. 708-713 (2000). |
Y. Cheng et al., “Caspase Inhibitor Affords Neuroprotection with Delayed Administration in a Rat Model of Neonatal Hypoxic-Ishemic Brain Injury,” J. Clin. Invest., 101, pp. 1992-1999 (1998). |
R.M. Friedlander et al., “ICE, Neuronal Apoptosis and Neurodegeneration,” Cell Death and Differentiation, 5, pp. 823-831 (1998). |
R.M. Friedlander, “Role of Caspase 1 in Neurologic Disease,” Arch. Neurol., 57, pp. 1273-1276 (2000). |
S.R. Grobmeyer et al., “Peptidomimetic Fluoromethylketone Rescues Mice from Lethal Endotoxic Shock,” Molec. Med., 5, pp. 585-594 (1999). |
M.E. McAlindon et al., “Investigation of the Expression of IL-1β Converting Enzyme and Apoptosis in Normal and Inflammatory Bowel Disease (IBD) Mucosal Macrophages,” Clin. Exp. Immunol., 116, pp. 251-257 (1999). |
P.J. Sansonetti et al., “Caspase-1 Activation of IL-1β and IL-18 are Essential for Shigella flexneri-Induced Inflammation,” Immunity, 12, pp. 581-590 (2000). |
G.S. Schierle et al., “Caspase Inhibition Reduces Apoptosis and Increases Survival of Nigral Transplants,” Nature Med., 5, pp. 97-100 (1999). |